Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,061,140
-$627,630 QoQ
Shares Held
168,652
+1.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#679
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Providence Capital Advisors, LLC holds $29,086,080 across 11 Drug Manufacturers - General names. PFE ranks #4 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
32,898 | $5,155,774 | |
| 2 | ABBV |
AbbVie Inc.
|
18,952 | $4,769,081 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
82,081 | $4,729,507 | |
| 4 | PFE |
Pfizer Inc
This page
|
168,652 | $4,061,140 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,948 | $3,976,818 | |
| 6 | SNY |
Sanofi
|
85,773 | $3,659,076 | |
| 7 | JNJ |
Johnson & Johnson
|
7,395 | $1,878,108 | |
| 8 | LLY |
ELI LILLY & Co
|
602 | $722,056 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,061,140 | 168,652 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $4,688,770 | 166,979 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,180,809 | 167,904 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,135,225 | 162,293 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,825,193 | 157,805 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,934,194 | 115,793 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,033,917 | 114,358 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,297,684 | 113,949 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,165,741 | 113,143 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,088,242 | 111,288 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,358,160 | 81,909 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,870,730 | 86,546 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,539,120 | 151,012 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $6,124,569 | 150,112 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $7,530,435 | 146,964 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $6,377,976 | 145,749 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $7,622,745 | 145,389 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $8,373,642 | 161,747 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $8,901,846 | 150,751 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,824,181 | 158,665 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $5,822,230 | 148,678 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $5,238,858 | 144,600 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $5,355,376 | 145,487 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,699,870 | 128,062 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,176,742 | 127,729 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $4,240,811 | 129,927 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||